GGrantIndex
← Search

Functional Genomics Shared Resource

$236,614P30FY2013CANIH

Vanderbilt University, Nashville TN

Investigators

Linked publications, trials & patents

Trial NCT07016399Trial NCT06593106Trial NCT05501665Trial NCT05361720Trial NCT04765072Trial NCT02702310Trial NCT02685631Trial NCT02677883Trial NCT02676752Trial NCT02672475Trial NCT02658487Trial NCT02600533Trial NCT02489422Trial NCT02480114Trial NCT02457910Trial NCT02448225Trial NCT02440737Trial NCT02374931Trial NCT02359851Trial NCT02324881Trial NCT02296112Trial NCT02269111Trial NCT02240381Trial NCT02236546Trial NCT02170272Trial NCT02151539Trial NCT02148406Trial NCT01996527Trial NCT01928160Trial NCT01901367Trial NCT01660971Trial NCT01230515Trial NCT01198535Trial NCT01141218Trial NCT01098669Trial NCT01098643Trial NCT01096407Trial NCT01096394Trial NCT01096381Trial NCT01077440Trial NCT01031446Trial NCT01013506Trial NCT01009931Trial NCT01007422Trial NCT00993694Trial NCT00993135Trial NCT00987766Trial NCT00984542Trial NCT00984490Trial NCT00983268Trial NCT00957736Trial NCT00949052Trial NCT00930930Trial NCT00900406Trial NCT00900003Trial NCT00899769Trial NCT00899626Trial NCT00899457Trial NCT00899301Trial NCT00899028Trial NCT00898742Trial NCT00898638Trial NCT00898430Trial NCT00898313Trial NCT00897988Trial NCT00897832Trial NCT00897793Trial NCT00897650Trial NCT00897468Trial NCT00897403Trial NCT00897117Trial NCT00896948Trial NCT00896675Trial NCT00892801Trial NCT00875238Trial NCT00840814Trial NCT00837876Trial NCT00835679Trial NCT00801346Trial NCT00765245Trial NCT00755040Trial NCT00675636Trial NCT00670644Trial NCT00670605Trial NCT00670046Trial NCT00666211Trial NCT00656604Trial NCT00653250Trial NCT00651976Trial NCT00651716Trial NCT00647218Trial NCT00626873Trial NCT00625417Trial NCT00625066Trial NCT00616590Trial NCT00601991Trial NCT00573404Trial NCT00550537Trial NCT00544648Trial NCT00533884

Abstract

The Functional Genomics Shared Resource (FGSR) of Vanderbilt-lngram Cancer Center (VICC) provides cancer center members with cutting-edge services and support related to a battery of contemporary genomic technologies including microarray, deep-sequencing, and RNAi screening efforts. The resource was formally established in 2000 as the Vanderbilt Microarray Shared Resource (VMSR), and began by offering limited services based principally on spotted cDNA microarrays and a handful of Affymetrix products. Due to strong interest among Vanderbilt faculty and aggressive management, the VMSR grew quickly, both in terms of its user base and the menu of services it offered. Because genomic technologies are naturally suited for analysis of cancer-relevant processes, and because VICC members were among the most active users of the VMSR, the resource was proposed and favorably reviewed (Outstanding rating) as a formal VICC shared resource in the 2004 CCSG renewal as the DNA Microarray shared resource. Since that fime, the resource has been in an almost constant state of evolufion to keep pace with the highly dynamic nature of genomic technologies, ensuring that VICC members have access to the most contemporary and powerful technologies in this area. Our goal is to provide one-stop shopping for scientiflc services related to the analysis or manipulation of genefic informafion. Reflecting this goal, the resource was renamed in September 2009 as the Functional Genomics Shared Resource (FGSR), an appropriate recognifion of the fact that modern genomic studies no longer are solely microarray-based, but rather encompass microarray, high-throughput quantitative PCR, and deep sequencing approaches, as well as high-content efforts for gene/pathway identiflcation via RNAi screening. Although the name and capabilifies of the resource have changed over the years, our mission to comprehensively support the genomic needs of VICC investigators with the most efficient and effective technologies available remains unchanged. The FGSR now provides a comprehensive and centralized resource to support a wide variety of genomic studies, with services ranging from nucleic acid quality control to sample processing utilizing a diverse collection of analysis platforms for DNA and RNA discovery, to high-end analysis and statistical support of the resulting data sets.

View original record on NIH RePORTER →